News Quantified

OPRX – optimizerx corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]

OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]

-17.4%

BEAT

34.7%

BEAT

19.7%

BEAT

55.4%

BEAT

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.

Form 3 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.

Form 4 OptimizeRx Corp For: Oct 01 Filed by: D'Silva Andrew J.

Form 10-Q OptimizeRx Corp For: Sep 30

Form 8-K OptimizeRx Corp For: Nov 06

Top News Gainers

3/16 Form NT 10-K OptimizeRx Corp For: Dec 31 31.9%

12/9 OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook 16.4%

5/8 Q1/2019 3/31/2019 EPS 0.060 ZacksConsensus -0.010 ActVsEst 0.070 - Beat 15.6%

1/29 OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform 13.2%

3/6 Form 8-K OptimizeRx Corp For: Mar 05 8.8%

4/16 OptimizeRx Sets First Quarter 2020 Conference Call for Monday, May 4, 2020 at 4:30 p.m. ET 8.7%

8/7 Q2/2019 6/30/2019 EPS 0.090 ZacksConsensus 0.030 ActVsEst 0.060 - Beat 8.4%

5/14 OptimizeRx Co. (NASDAQ: OPRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $16.00 price target on the stock. 6.9%

3/12 Form 8-K OptimizeRx Corp For: Mar 11 6.8%

3/10 OptimizeRx Launches ‘Digital Healthcare’ Webinar Series 5.8%

Top News Decliners

4/17 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -27.7%

2/28 Form 8-K OptimizeRx Corp For: Feb 27 -18.5%

3/18 OptimizeRx to Host Online Session with Clinical Leaders at Microsoft, Massachusetts General Hospital and BD -15.7%

11/5 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus 0.060 ActVsEst (0.110) - Miss -13.8%

3/26 Form 10-K OptimizeRx Corp For: Dec 31 -9.6%

3/9 OptimizeRx Digital Health Network Now Delivering CDC Coronavirus Alerts to Thousands of Healthcare Providers Nationwide -9.0%

3/13 Form 4 OptimizeRx Corp For: Mar 11 Filed by: BAKER DOUGLAS P -7.6%

1/18 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.7%

11/5 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -4.4%

8/9 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day